Close Menu

Linguamatics

CRO and analytics giant IQvia, the product of the IMS Health-Quintiles merger, quietly purchased UK-based bioinformatics company Linguamatics a month ago.

Linguamatics' I2E natural language processing engine helps Sanofi match HLA alleles with multiple sclerosis and associated drug treatments.

Version 5.0 of the software features tools for normalizing concepts such as gene mutations and additional query features for mining text documents.

CollabRx has launched CancerRx, a new oncology application that runs on Apple's operating system. The app provides oncologists and pathologists with treatment options that are based on their patients' tumors and also offers a daily newsfeed from MedPage Today.

RefSeq 65 is now available from the National Center for Biotechnology Information via FTP.

Linguamatics said this week that it exceeded $10 million in sales last year outperforming both growth and sales expectations.

Linguamatics said this week that researchers at the University of Utah's Huntsman Cancer Institute are using Linguamatics I2E, the company's text mining software solution, to extract information from electronic health records that could help them better understand cancer and impr

Agilent Technologies has released a new version of its electronic laboratory notebook software.

The TranSMART Foundation has launched a new version of the open source knowledge management platform.

Text mining software developer Linguamatics has been selected as a commercial partner in a two-year research project funded by the European Commission’s Seventh Framework Program that is focused on improving multilingual terminologies in biomedicine.

Pages

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

Newsweek discusses the privacy issues raised by digital medicine.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.